Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 200 of 467 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 06/30/10
Due: 06/30/11
A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose
Phase: N/A
Priority: Normal
Start: 10/19/22
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 07/31/97
End: 12/31/02
Due: 12/31/03
Phase: N/A
Priority: Normal
Start: 12/31/02
End: 06/30/09
Due: 06/30/10
Phase: N/A
Priority: Normal
Start: 05/31/97
End: 06/30/09
Due: 06/30/10
Phase: N/A
Priority: Normal
Start: 08/31/08
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 09/30/12
End: 03/31/14
Due: 03/31/15
Phase: N/A
Priority: Normal
Start: 08/04/15
End: 07/23/17
Due: 07/23/18
Phase: N/A
Priority: Normal
Start: 08/18/10
End: 02/01/17
Due: 02/01/18
Phase: N/A
Priority: Normal
Start: 01/31/98
End: 01/31/12
Due: 01/31/13
Phase: N/A
Priority: Normal
Start: 04/30/04
End: 02/28/06
Due: 02/28/07
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 08/31/15
Due: 08/31/16
Phase: N/A
Priority: Normal
Start: 08/06/20
End: 09/25/23
Due: 09/25/24
Phase: N/A
Priority: Normal
Start: 10/31/22
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 01/13/20
End: 05/27/21
Due: 05/27/22
Phase: N/A
Priority: Normal
Start: 10/04/24
End: 06/14/28
Due: 06/14/29
Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia
Phase: N/A
Priority: Normal
Start: 07/31/10
End: 05/31/14
Due: 05/31/15
Phase: N/A
Priority: Normal
Start: 07/31/00
End: 04/30/02
Due: 04/30/03
Phase: N/A
Priority: Normal
Start: 01/31/17
End: 07/31/18
Due: 07/31/19
Phase: N/A
Priority: Normal
Start: 09/25/17
End: 04/13/18
Due: 04/13/19
Phase: N/A
Priority: Normal
Start: 04/30/12
End: 01/31/14
Due: 01/31/15
Phase: N/A
Priority: Normal
Start: 09/30/99
End: 09/30/04
Due: 09/30/05
Phase: N/A
Priority: Normal
Start: 10/17/16
End: 04/29/20
Due: 04/29/21
Phase: N/A
Priority: Normal
Start: 09/22/15
End: 12/14/19
Due: 12/14/20
Phase: N/A
Priority: Normal
Start: 10/25/15
End: 01/10/19
Due: 01/10/20